- Home
- JDZG vs GOVX Comparison
JDZG vs GOVX Comparison
Compare JDZG & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- GOVX
- Stock Information
- Founded
- JDZG 2020
- GOVX 2001
- Country
- JDZG China
- GOVX United States
- Employees
- JDZG N/A
- GOVX N/A
- Industry
- JDZG Other Consumer Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- GOVX Health Care
- Exchange
- JDZG Nasdaq
- GOVX Nasdaq
- Market Cap
- JDZG 7.5M
- GOVX 7.6M
- IPO Year
- JDZG 2024
- GOVX N/A
- Fundamental
- Price
- JDZG $1.86
- GOVX $0.76
- Analyst Decision
- JDZG
- GOVX Strong Buy
- Analyst Count
- JDZG 0
- GOVX 4
- Target Price
- JDZG N/A
- GOVX $10.50
- AVG Volume (30 Days)
- JDZG 131.2K
- GOVX 1.2M
- Earning Date
- JDZG 08-26-2025
- GOVX 07-28-2025
- Dividend Yield
- JDZG N/A
- GOVX N/A
- EPS Growth
- JDZG N/A
- GOVX N/A
- EPS
- JDZG 0.25
- GOVX N/A
- Revenue
- JDZG $2,567,741.00
- GOVX $6,143,044.00
- Revenue This Year
- JDZG N/A
- GOVX N/A
- Revenue Next Year
- JDZG N/A
- GOVX N/A
- P/E Ratio
- JDZG $7.43
- GOVX N/A
- Revenue Growth
- JDZG 20.36
- GOVX 1943.07
- 52 Week Low
- JDZG $1.58
- GOVX $0.43
- 52 Week High
- JDZG $21.28
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- GOVX 51.62
- Support Level
- JDZG N/A
- GOVX $0.66
- Resistance Level
- JDZG N/A
- GOVX $0.75
- Average True Range (ATR)
- JDZG 0.00
- GOVX 0.05
- MACD
- JDZG 0.00
- GOVX 0.01
- Stochastic Oscillator
- JDZG 0.00
- GOVX 62.30
About JDZG JIADE LIMITED Common stock
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.